Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PYC Therapeutics.
RELATED STOCKHEAD STORIES
News
Hot Money Monday: Momentum trading has been a popular strategy for decades, and here’s how you can use it
Health & Biotech
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
Health & Biotech
ASX Health Stocks: 4DX skyrockets 54pc after US update on its XV LVAS scanning device
Health & Biotech
ASX Health Stocks: PYC on the same page with FDA, Cleo’s cancer test peer-reviewed
News
Market Highlights: Wall Street skids ahead of CPI; Wegovy could be ‘top selling drug in history’
Health & Biotech
ASX Health Stocks: PYC granted FDA Fast Track; BCAL announces breakthrough results
Health & Biotech
ASX Health Stocks: Successful toxicology tests pave the way for PYC’s Phase 2 clinical trial
News
CLOSING BELL: The ASX dips while we ‘hurry up and wait’ to see what The Budget holds
Health & Biotech
ASX Health Stocks: CardieX jumps 16pc after FDA clearance; 3 other ASX biotechs to commence trials
Health & Biotech
ASX Health Stocks: PYC to take second asset to clinical trial; FDA sees no issues in Botanix submission
Health & Biotech
ASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTAT
Health & Biotech
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger
Health & Biotech
ASX Health Stocks: Sonic snaps up stake in Microba, sending MAP share price 60pc higher
Health & Biotech
ASX Biotech Stocks: Medibank says nope to paying ransom for data theft
Health & Biotech
ASX Health Stocks: Race to develop RNA-based therapies is well and truly on, as these two biotechs add new programs
News
Market Highlights: Dow Jones officially in bear market and 5 ASX small caps to watch on Tuesday
Health & Biotech
